Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Alimera Sciences Inc. je 32.75%
Inštitucionálne vlastníctvo (Institutional Ownership) je množstvo akcií spoločnosti vlastených podielovými alebo penzijnými fondami, poisťovňami, investičnými firmami, a ďalšími entitami, ktoré spravujú peňažné prostriedky iných.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.